Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

Author:

Coomans Marijke B1,Dirven Linda12,Aaronson Neil K3,Baumert Brigitta G45,Van Den Bent Martin6,Bottomley Andrew7,Brandes Alba A8,Chinot Olivier9,Coens Corneel7,Gorlia Thierry10,Herrlinger Ulrich11,Keime-Guibert Florence12,Malmström Annika13,Martinelli Francesca7,Stupp Roger14,Talacchi Andrea15,Weller Michael16ORCID,Wick Wolfgang17,Reijneveld Jaap C18,Taphoorn Martin J B12

Affiliation:

1. Department of Neurology, Leiden University Medical Center, Leiden, Netherlands

2. Department of Neurology, Haaglanden Medical Center, Den Haag, Netherlands

3. Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands

4. Department of Radiation-Oncology, University Hospital Bonn, Bonn, Germany

5. Department of Radiation Oncology (MAASTRO Clinic), and GROW (School for Oncology and Developmental Biology), Maastricht University Medical Center, Maastricht, Netherlands

6. the Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, Netherlands

7. Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium

8. Department of Medical Oncology, Local Health Unit Company–Institute of Hospitalization and Scientific Care (Azienda USL-IRCCS), Institute of Neurological Sciences, Bologna, Italy

9. Aix-Marseille University, Neurophysiopathology Institute, University Hospital Center Timone, Neuro-Oncology Service, Marseille, France

10. European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium

11. Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany

12. Pitié-Salpetrière Hospital Group, Paris, France

13. Department of Advanced Home Care and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

14. Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA

15. Department of Neurosciences, San Giovanni Addolorata Hospital, Rome, Italy

16. Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland

17. Neurology Clinic and National Centre for Tumour Diseases, University Hospital Heidelberg, Heidelberg, Germany, and German Consortium of Translational Cancer Research, Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany

18. Department of Neurology and Brain Tumour Center Amsterdam, Amsterdam University Medical Center, Amsterdam, Netherlands

Abstract

Abstract Background Symptom management in glioma patients remains challenging, as patients suffer from various concurrently occurring symptoms. This study aimed to identify symptom clusters and examine the association between these symptom clusters and patients’ functioning. Methods Data of the CODAGLIO project was used, including individual patient data from previously published international randomized controlled trials (RCTs) in glioma patients. Symptom prevalence and level of functioning were assessed with European Organisation for Research and Treatment of Cancer (EORTC) quality of life QLQ-C30 and QLQ-BN20 self-report questionnaires. Associations between symptoms were examined with Spearman correlation coefficients and partial correlation networks. Hierarchical cluster analyses were performed to identify symptom clusters. Multivariable regression analyses were performed to determine independent associations between the symptom clusters and functioning, adjusted for possible confounders. Results Included in the analysis were 4307 newly diagnosed glioma patients from 11 RCTs who completed the EORTC questionnaires before randomization. Many patients (44%) suffered from 5–10 symptoms simultaneously. Four symptom clusters were identified: a motor cluster, a fatigue cluster, a pain cluster, and a gastrointestinal/seizures/bladder control cluster. Having symptoms in the motor cluster was associated with decreased (≥10 points difference) physical, role, and social functioning (betas ranged from −11.3 to −15.9, all P < 0.001), independent of other factors. Similarly, having symptoms in the fatigue cluster was found to negatively influence role functioning (beta of −12.3, P < 0.001), independent of other factors. Conclusions Two symptom clusters, the fatigue and motor cluster, were frequently affected in glioma patients and were found to independently have a negative association with certain aspects of patients’ functioning as measured with a self-report questionnaire.

Funder

EORTC Quality of Life Group

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Reference53 articles.

1. Complete prevalence of malignant primary brain tumors registry data in the United States compared with other common cancers, 2010;Zhang;Neuro Oncol.,2016

2. Symptom management and quality of life in glioma patients;Boele;CNS Oncol.,2014

3. Incidence of neurologic deficits and rehabilitation of patients with brain tumors;Mukand;Am J Phys Med Rehabil.,2001

4. Symptom evaluation in palliative medicine: patient report vs systematic assessment;Homsi;Support Care Cancer.,2006

5. A review of the prevalence and impact of multiple symptoms in oncology patients;Esther Kim;J Pain Symptom Manage.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3